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Background: Peritoneal dissemination is the most common type of recurrence in advanced gastric cancer. The
main mechanism is thought to be via the exfoliation of free cancer cells (FCCs) from tumor in the gastric serosa.
The frequency of recurrence thus increases once the tumor cells penetrate the serosa. However, this type of
recurrence also occurs in patients without serosal invasion, though the mechanisms responsible for have not been
fully established. We therefore investigated the factors associated with peritoneal dissemination in patients with
non-serosa-invasive gastric cancer.
Methods: A total of 685 patients with non-serosa-invasive gastric cancer who underwent curative resection with
retrieval of more than 15 nodes were selected. The associations between clinicopathological features and peritoneal
dissemination were analyzed. Among them, the tumor infiltrating growth pattern (INF) were classified into α, β and
γ according to the Japanese Classification of Gastric Carcinoma (JCGC).
Results: The overall incidence of peritoneal metastasis was 20% (137/685). Age, Borrmann type, differentiation, INF,
nodal status and free cancer cells (FCCs) were correlated with peritoneal dissemination using univariate analysis.
However, only INF, Borrmann type and TNM node stage were identified as independent correlated factors with
peritoneal metastasis by multivariate analysis when FCCs were excluded, and these were also prognostic factors.
Peritoneal dissemination was more common in patients with INFγ, Borrmann III/IV and N3 stage. Among patients
without FCCs, nodal involvement or vessel invasion, only INF remained an independent associated factor according
to multivariate analysis.
Conclusions: Tumor infiltrating growth pattern (INF), together with Borrmann type and TNM node stage, are
important factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer.
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Although the incidence of gastric cancer is declining, it
remains the second leading cause of cancer-related mor-
tality worldwide. It is also the second most prevalent
malignancy in China [1-3]. The incidences of recurrence
and metastasis mean that the prognosis for advanced
gastric cancer has improved little, despite the use of po-
tentially curative resection. Peritoneal dissemination
represents the most common type of recurrence. The* Correspondence: xuhuimian@126.com
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reproduction in any medium, provided the ormain mechanism of peritoneal metastasis is thought to
be via exfoliation of free cancer cells (FCCs) from tumor
in the gastric serosa, and the frequency of peritoneal me-
tastasis therefore increases once the tumor cells pene-
trate the serosa, with incidences ranging from 30–60%
[4-6]. However, this type of recurrence is also found in
patients without serosal invasion. It has been reported
that approximately 0.5–2.0% of patients with early gas-
tric carcinoma and 5–11% of patients with non-serosa-
invasive gastric carcinoma develop peritoneal recurrence
after curative surgery [4,7]. However, the mechanisms
responsible for and the factors associated with this type
of recurrence remain unknown. Fink and LongmireLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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channels and spread viable cancer cells into the intraper-
itoneal cavity [8]. Kodera et al. thought that cancer cells
could infiltrate through the capsule of metastatic lymph
nodes to cause metastasis in the peritoneal mesothelium
[9]. Tanaka et al. considered that tumor cell obstruction
of the lymph vessels could result in the establishment of
peritoneal metastasis [10]. All these studies focused on
the roles of metastatic lymph nodes in peritoneal dis-
semination; however, some patients without FCCs, or
nodal or vessel involvement still develop peritoneal me-
tastasis. This suggests that some factors other than FCCs
and lymph node status may be associated with peritoneal
dissemination, though no clear and definite results have
yet been reported.
The depth of muscularis propria (MP) invasion is sub-
classified into superficial MP (sMP) and deep MP
(dMP). Patients with dMP invasion have been reported
to have similar prognoses to those with subserosal (SS)
invasion, while patients with sMP invasion have a better
prognosis, similar to early gastric cancer [11]. In the
present study, we therefore examined the association be-
tween peritoneal dissemination and clinicopathological
features in a total of 685 patients with either dMP or SS




This study was a retrospective analysis of a gastric-
cancer database collected prospectively from February
1980 to November 2006, at the Department of Surgical
Oncology, First Affiliated Hospital, China Medical Uni-
versity. A total of 692 patients with dMP or SS inva-
sion were included, all of whom underwent potentially
curative surgery (R0) with the retrieval of more thanFigure 1 Predominant pattern of tumor infiltrating growth into the su
INFα: tumor shows expanding growth and a distinct border with the surro
indistinct border with the surrounding tissue (Figure 1 C); INFβ: intermedia15 lymph nodes. At the end of the follow-up period in
December 2008, two patients had died during the
postoperative period and five patients had been lost to
follow-up, giving a follow-up rate of 99%. A total of 685
patients with non-serosa-invasive gastric cancer were
therefore enrolled in this study and gave their informed
consent. The median follow-up period was 30 months
(range 3–297 months).
The follow-up program was performed every 3 months
for the first 2 postoperative years, and every 6 months
thereafter. The diagnosis of peritoneal recurrence was
made on the basis of clinical symptoms, digital examin-
ation, or physical, ultrasonographic and radiological
findings of bowel obstruction, peritoneal nodules or as-
cites. All recurrences were confirmed by radiography or
histopathology, or both. A total of 137 patients (20%)
were diagnosed with peritoneal metastasis during the
follow-up period.
Clinicopathological factors
The histopathological features were determined by
hematoxylin and eosin staining of paraffin sections.
Intraoperative cytological examination was performed
as follows. Briefly, immediately after the abdominal
cavity was opened, 100 ml of physiological saline was
introduced into the Douglas cavity, aspirated after gen-
tle stirring, and centrifuged at 2000 rpm for 10 min to
collect intact cells. Using the Thin Prep procedure,
two slide preparations were made. The first was
stained with a modified hematoxylin and eosin prepar-
ation and the second using the Papanicolaou method.
Each slide was classified as inadequate, negative, or
positive. Slide preparations were considered inadequate
if there was insufficient cellular material for a diagno-
sis, and if blood coloration was so heavy that it pre-
vented cellular examination. Sections were reviewed inrrounding tissue. Infiltrating growth pattern was classified as follows:
unding tissue (Figure1 A); INFγ: tumor shows infiltrating growth and an
te between INFγ and INFβ (Figure 1 B) (hematoxylin and eosin, ×40).







Sex male 394 (82) 88 (18) 3.01 0.08
female 154 (76) 49 (24)
Site lower 359 (80) 91 (20) 0.95 0.81
middle 74 (83) 15 (17)
upper 92 (78) 22 (26)
entire 23 (82) 5 (18)
Age (year) mean (SD) 58.4 (10.3) 56.7 (12.2) 2.88* 0.09
Size (cm) mean (SD) 5.4 (2.4) 5.7 (2.5) 1.64* 0.20
Infiltrating pattern INF α/β 317 (88) 42 (12) 32.49 <0.01
INF γ 231 (71) 95 (29)
Differentiation well/moderate 175 (86) 29 (14) 6.08 0.01
poor 373 (78) 108 (22)
Borrmann type I/II 97 (90) 11 (10) 7.72 <0.01
III/IV 451 (78) 126 (22)
Lauren type intestinal 172 (85) 30 (15) 4.88 0.09
mixed 17 (81) 4 (19)
diffuse 359 (78) 103 (22)
Depth of invasion dMP 106 (86) 17 (14) 3.58 0.06
SS 442 (79) 120 (21)
Lymphatic/venous
invasion
- 444 (80) 109 (20) 0.15 0.69
+ 104 (79) 28 (21)
TNM stage N0(0) 170 (86) 27 (14) 23.21 <0.01
N1 (1–2) 114 (81) 27 (19)
N2 (3–6) 128 (85) 23 (15)
N3a (7–15) 101 (72) 39 (28)
N3b (>15) 35 (63) 21 (37)
JCGC stage N0 170 (86) 27 (14) 15.57 <0.01
N1 173 (83) 36 (17)
N2 184 (75) 62 (25)
>N3 21 (64) 12 (36)
FCCs # negative 84 (85) 15 (15) 27.46 <0.01
positive 4 (25) 12 (75)
* Unpaired t-test; # analysis only included 115 patients with intraoperative
cytological examination.
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gists to confirm the diagnosis. In the event of a dis-
agreement, the opinion of a third expert was sought
who was blinded to both diagnoses. During the study
period, 115 samples were eligible for analysis, and a
total of 16 patients were confirmed positive for peri-
toneal FCCs. The cancer cells predominant patterns of
infiltrating growth into the surrounding tissue (INF)
were classified according to the Japanese Classification
of Gastric Carcinoma (JCGC) [12] as follows: INFα:
tumor shows expanding growth and a distinct border
with the surrounding tissue; INFγ: tumor shows infil-
trating growth and an indistinct border with the sur-
rounding tissue; INFβ: intermediate between INFα and
INFγ. This classification has been applied in our insti-
tute since 1980. Figure 1 shows the detailed patho-
logical characteristics of the three types of INF.
Among the 685 patients, 123 were diagnosed with
pathologically-proven dMP invasion and 562 with SS in-
vasion. INFα/β was found in 359 patients (52%), and
INFγ in 326 patients (48%). Regarding macroscopic type,
Borrmann type I/II was found in 108 patients (16%), and
Borrmann type III/IV in 577 patients (84%). The detailed
clinicopathological information is listed in Table 1. The
study protocol was approved by the Ethics Committee of
China Medical University.
Statistical analysis
Data were analyzed using SPSS statistical software
(SPSS, Chicago, IL). Univariate analysis was carried out
using the χ2 test to determine the significance of differ-
ences between categorical variables and unpaired t-tests
for continuous variables. Multivariate analysis was per-
formed using binary logistic regression with the back-
ward conditional method. Survival analysis was carried
out using the Kaplan-Meier estimation and log-rank test.
Prognostic factors were assessed using the Cox propor-
tional hazards model. For all analyses, values of P < 0.05
were considered significant.
Results
Univariate and multivariate analyses of peritoneal
metastasis
The incidence of peritoneal metastasis was 14% (17/123) in
dMP-invasive and 21% (120/562) in SS-invasive cancers.
Among all the patients, age, Borrmann type, differentiation,
INF and nodal status (TNM or JCGC node stage) were
correlated with peritoneal dissemination according to uni-
variate analysis (Table 1). However, only INF, Borrmann
type and TNM node stage were independent associated
factors according to multivariate analysis, when FCCs were
omitted. The incidence of peritoneal dissemination was
much higher in patients with INFγ, Borrmann III/IV, and
N3 stage based on UICC/TNM classification. The oddratios (ORs) of peritoneal metastasis was 2.92 (95% confi-
dence interval [CI]: 1.94–4.40; P < 0.001) for patients with
INFγ, and 2.06 (95% CI: 1.05–4.04; P = 0.035) for
patients with Borrmann III/IV, and 2.07 (95% CI:
1.18–3.63; P = 0.012) for patients with N3a, and 3.44
(95% CI: 1.71–6.92; P = 0.001) for patients with N3b, com-
pared with their counterparts, respectively (Table 2).
In this database, only 115 patients underwent intrao-
perative cytological examinations in recent years, and
were analyzed further. Among these patients, FCCs in




P value OR 95.0% CI for OR
lower upper
Borrmann type I/II 108 1
Borrmann type III/IV 577 0.04 2.06 1.05 4.04
Infiltration pattern α/β 359 1
Infiltration pattern γ 326 <0.01 2.92 1.94 4.40
TNM node stage
N0 (0) 197 1
N1 (1–2) 141 0.18 1.50 0.83 2.74
N2 (3–6) 151 0.74 1.11 0.60 2.05
N3a (7–15) 140 0.01 2.07 1.18 3.63
N3b (>15) 56 <0.01 3.44 1.71 6.92
Table 3 Relationship between infiltrating growth pattern
and other clinicopathological factors
Factors INFα/β INFγ χ2 P value
Sex male 270 (56) 212 (44) 8.49 <0.01
female 89 (44) 114 (56)
Site lower 240 (53) 210 (47) 4.07 0.25
middle 40 (45) 49 (55)
upper 67 (57) 51 (43)
entire 12 (43) 16 (57)
Age (year) mean (SD) 59.6 (9.9) 56.4 (11.3) 15.36* <0.01
Size (cm) mean (SD) 5.4 (2.2) 5.6 (2.6) 0.62* 0.43
Differentiation well/moderate 164 (80) 40 (20) 91.21 < 0.01
poor 195 (41) 286 (59)
Borrmann type I/II 65 (60) 43 (40) 3.11 0.08
III/IV 294 (51) 283 (49)
Lauren type intestinal 162 (80) 40 (20) 94.59 < 0.01
mixed 14 (67) 7 (33)
diffuse 183 (40) 279 (60)
Depth of invasion dMP 64 (52) 59 (48) 0.01 0.93
SS 295 (53) 267 (47)
Lymphatic/venous
invasion
- 294 (53) 259 (47) 0.66 0.42
+ 65 (49) 67 (51)
TNM stage N0 (0) 110 (56) 87 (44) 9.48 < 0.05
N1 (1–2) 81 (57) 60 (43)
N2 (3–6) 83 (55) 68 (45)
N3a (7–15) 59 (42) 81 (58)
N3b (>15) 26 (46) 30 (54)
JCGC stage N0 110 (56) 87 (44) 4.66 0.20
N1 116 (56) 93 (44)
N2 119 (48) 127 (52)
>N3 14 (42) 19 (58)
FCCs # negative 55 (56) 44 (44) 7.46 <0.01
positive 3 (19) 13 (81)
* Unpaired t-test; # analysis only included 115 patients with intraoperative
cytological examination.
Huang et al. BMC Cancer 2013, 13:57 Page 4 of 8
http://www.biomedcentral.com/1471-2407/13/57the peritoneal cavity were closely related to peritoneal
dissemination according to univariate analysis (Table 1).
Moreover, FCCs was the only factor associated with peri-
toneal metastasis after multivariate analysis (OR=16.80,
95% CI: 4.78-59.10; P < 0.001). Borrmann type, INF and
TNM node stage were excluded from the model when
FCCs was added.
Multivariate analysis of peritoneal dissemination in
patients without FCCs, node metastasis or lymphatic/
venous invasion
Regarding lymph node metastasis, lymphatic/venous in-
vasion and FCCs to be important factors influencing
peritoneal dissemination, we therefore further assessed
the factors associated with peritoneal dissemination in
all the patients without nodal involvement, vessel inva-
sion, or positive FCCs. A total of 180 patients were
included, 23 of whom had peritoneal dissemination. INF
remained an independent correlated factor according to
multivariate analysis. The OR of peritoneal metastasis
was 3.901 (95% CI: 1.516–10.046; P = 0.005) for patients
with INFγ compared with INFα or β.
Apart from nodal status and FCCs, INF was the de-
cisive factor associated with peritoneal dissemination in
non-serosa-invasive gastric cancer. The relationship be-
tween INF and other clinicopathological factors was
therefore assessed further. INF was significantly correlated
with age, sex, differentiation, Lauren type, TNM node stage
and FCCs. INFγ was more common in younger and female
patients and those with poor differentiation, diffuse type,
N3 stage and positive FCCs (Table 3).
Survival analysis
Prognosis was further analyzed among all the patients
based on the different clinicopathological factors. When
the 12 clinicopathological factors were added into the
multivariate Cox regression model simultaneously, INF,Borrmann type, and nodal status were also identified as
independent prognostic factors (Table 4). Poorer sur-
vival was seen in patients with INFγ (HR 1.41, P < 0.01),
Borrmann III/IV (HR 1.60, P < 0.01), and with increased
TNM node stage (HR 3.01-6.92, P < 0.01). The survival
curves in relation to INF, Borrmann type and TNM node
stage are shown in Figures 2,3, and 4.
Discussion
FCCs in the peritoneal cavity is recognized as the most
important factor influencing peritoneal dissemination
[9,13]. In our clinical practice, cytological examination
was performed immediately after the abdominal cavity
Table 4 Multivariate analysis of prognostic factors for
disease-free survival in non-serosa-invasive gastric cancer#
Factor Number of
patients




middle 89 0.85 1.04 0.73 1.47
upper 118 <0.01 1.47 1.12 1.94
entire 28 0.26 1.32 0.81 2.17
Borrmann type
I/II 108 1
III/IV 577 <0.01 1.60 1.16 2.21
Depth of invasion
dMP 123 1
SS 562 <0.01 1.57 1.16 2.13
Infiltrating pattern
INF α/β 359 1
INF γ 326 <0.01 1.41 1.14 1.75
TNM node stage
N0 (0) 197 1
N1 (1–2) 141 <0.01 3.01 1.17 5.31
N2 (3–6) 151 <0.01 3.32 1.97 5.59
N3a (7–15) 140 <0.01 5.54 3.38 9.09
N3b (>15) 56 <0.01 6.92 4.09 11.73
# Determined by multivariate Cox proportional hazards model.
Figure 2 Survival curves in relation to the tumor infiltrating growth p
to patients with INFα or β. The difference was significant (χ2 = 14.42, P < 0
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http://www.biomedcentral.com/1471-2407/13/57was opened, which reflected the true state of FCCs in
the peritoneal cavity. After surgical dissection, 43°C 4000
ml sterilized distilled water was lavaged in the peritoneal
cavity for 10 min. This guaranteed to kill FCCs as much
as possible, in order to decrease the incidence of peri-
toneal dissemination after surgery. Although there was a
low incidence of FCCs in non-serosa-invasive gastric
cancer, and only 115 patients were analyzed in this study,
FCCs were confirmed as the predominant influencing
factor for peritoneal metastasis, confirming the direct
role of FCCs in the development of peritoneal dissemin-
ation. Nodal status is also thought to influence peritoneal
metastasis. Theoretically, cancer cells could infiltrate
through the capsule of the metastatic nodes or vessel and
cause metastasis in the peritoneal mesothelium. Many
investigators have reported that lymphatic advancement
and lymph node metastasis contribute to the establish-
ment of peritoneal metastasis [9,10,14], and this idea was
supported by the results for non-serosa-invasive gastric
cancer in the current study. The incidence of peritoneal
dissemination increased with increasing TNM node
stage. Patients with more than seven metastatic lymph
nodes (N3) developed peritoneal dissemination more
easily after surgery.
Some factors other than FCCs and nodal status may
also be associated with peritoneal dissemination in non-
serosa-invasive gastric cancer. The Borrmann classifica-
tion system was developed in 1926 and is a valuable
clinicopathological tool that is widely used to describeattern. Prognosis worsened abruptly in patients with INFγ compared
.01) using log rank test.
Figure 3 Survival curves in relation to Borrmann type by Kaplan Meier estimation. Poorer survival was seen in patients with Borrmann type
III/IV compared to those with Borrmann type I/II. The difference was significant (χ2 = 16.59, P < 0.01) using log rank test.
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ies have shown that Borrmann type correlates with
tumor size, depth of invasion, histological grade, lymph
node involvement, tumor stage, distant metastasis and
prognosis [15-17]. In the present study, patients with
Borrmann stage III/IV were more likely to develop peri-
toneal metastasis than those with Borrmann stage I/II,
suggesting increased invasive and metastatic potentials
in Borrmann III/IV gastric cancers. Borrmann stage IVFigure 4 Survival curves in relation to 7th UICC/TNM node stage. Proggastric cancer has been considered as an independent
type in many studies [16,18].
The pattern of infiltrating growth into the surrounding
tissue (INF) based on JCGC classification has not been
widely used [19]. However, this classification system can
be easily utilized after simple training. In the present
study, the rate of peritoneal dissemination was higher in
patients with INFγ, compared to those with INFα or β.
After excluding interference by FCCs, metastatic nodesnosis worsened with increasing N stage (χ2 = 128.78, P < 0.01).
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factor associated with peritoneal dissemination, thus
confirming its role in peritoneal metastasis. A recent
study in Korea investigated the role of INF in peritoneal
metastasis in pT2b patients and confirmed that
infiltrative-type growth pattern was closely related to
peritoneal dissemination [20]. INF thus represents a
promising predictive factor for peritoneal metastasis in
non-serosa-invasive gastric cancer.
The reasons why INF plays such an important role in
peritoneal metastasis in non-serosa-invasive gastric can-
cer remains unclear. In the present study, INF was posi-
tively correlated with FCCs, Lauren type, differentiation
and TNM node stage. INFγ was more common in
patients with FCCs, diffuse type, poor differentiation and
late node stage (N3), all of which reflect malignant be-
havior. Thus INFγ tumors were more invasive than INFα
or β tumors, which could partly account for this
phenomenon, based on clinicopathological study. How-
ever, further molecular biological studies are needed to
confirm the precise mechanisms involved.
In this study, prognosis was assessed based on clinico-
pathological factors, and INF, Borrmann type, and nodal
status were determined to be independent prognostic
factors. The results of this study identified these three
factors as independent predictors for both prognosis and
peritoneal recurrence, thus confirming their valuable
roles in clinical practice.Conclusions
The results of this study suggest that tumor infiltrating
growth pattern (INF), together with Borrmann type and
UICC/TNM node stage, are important factors associated
with peritoneal metastasis in non-serosa-invasive gastric
cancer. Patients with INFγ, Borrmann stage III/IV, and
N3 stage should be closely followed-up to detect peri-
toneal dissemination.
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